Sodium-glucose cotransporter inhibition: Therapeutic potential for the treatment of type 2 diabetes mellitus

Medicine & Life Sciences

• Sodium-Glucose Transport Proteins 100%
• Type 2 Diabetes Mellitus 52%
• Glucose 35%
• Hyperglycemia 25%
• 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 21%
• Pioglitazone 17%
• Metformin 15%
• Kidney 15%
• Complementary Therapies 14%
• Insulin Secretion 14%
• Hypoglycemia 13%
• Urinary Tract Infections 13%
• Genitalia 13%
• Signs and Symptoms 12%
• Therapeutics 11%
• Homeostasis 10%
• Insulin 9%
• Randomized Controlled Trials 9%
• Clinical Trials 9%